Raymond James raised the price target for the The Clorox Company (NYSE:CLX) stock to “an Outperform”. The rating was released on July 13, 2022, according to finviz. We previously noted in another research note published on February 04, 2022 by Wells Fargo that reiterated the stock to an Underweight with a price target of $150 for CLX stock. The research report from UBS has reiterated the stock to Sell, with a price target set at $148. The stock was reiterated by Morgan Stanley, who disclosed in a research note on February 04, 2022, to Underweight and set the price objective to $140. In their research brief published February 04, 2022, JP Morgan analysts reiterated the The Clorox Company stock to Underweight with a price target of $137.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The latest trade, Performances and Moving Averages give us the following Picture
The share price of The Clorox Company (NYSE:CLX) dipped -4.71% to close Thursday’s market session at $137.76, lower as compared to yesterday’s close. The stock price fluctuated between $135.81 and $143.5336 throughout the trading session with the volume trading being 3325664 shares, which represented a significant variation when compared to the three months average volume of 1.38 million shares. The firm’s stock price fluctuated -4.78% within the last five trades and -6.07% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -17.50% in the last 6 months and -7.93% was subtracted to its value over the previous 3 months. CLX stock is trading at a margin of -5.34%, -1.82% and -9.89% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, CLX deals in the Consumer Defensive domain. The stock is trading -26.28 percent below its 52-week high and 14.32 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -17.8. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does The Clorox Company’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 8.10 percent and the profit margin is 6.40 percent, and the company has reported a gross margin of 35.80 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $17.01 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for The Clorox Company (NYSE:CLX) is 37.35. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 26.18. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 2.39 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 42.39, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.10 percent of The Clorox Company shares are owned by insiders, and 80.50 percent are held by financial institutions. MACKAY A D DAVID, the Director at The Clorox Company (CLX) has sold 1,000 shares of firm on Jun 02 at a price of $140.63 against the total amount of $0.14 million. In another inside trade, Reynolds Eric H, EVP – Chief Operating Officer of The Clorox Company (NYSE:CLX) sold 585 shares of the firm on May 09 for a total worth of $90576.0 at a price of $154.83. An inside trade which took place on Nov 16, SVP – GM, International of The Clorox Company Barral Diego J sold 240 shares of firm against total price of $40800.0 at the cost of $170.00 per share.